These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 33610082

  • 1. Evaluation of the intranasal steroid treatment outcomes in adenoid tissue hypertrophy with or without allergic rhinitis.
    Arslan E, Tulaci KG, Canakci H, Arslan S, Yazici H.
    Am J Otolaryngol; 2021; 42(4):102983. PubMed ID: 33610082
    [Abstract] [Full Text] [Related]

  • 2. [Clinical observation of mometasone furoate nasal spray combined with montelukast sodium in the treatment of adenoid hypertrophy in children].
    Liu W, Chen RJ.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar 05; 31(5):366-368. PubMed ID: 29871263
    [Abstract] [Full Text] [Related]

  • 3. Montelukast combined with intranasal mometasone furoate versus intranasal mometasone furoate; a comparative study in treatment of adenoid hypertrophy.
    Ras AE, Hamed MH, Abdelalim AA.
    Am J Otolaryngol; 2020 Mar 05; 41(6):102723. PubMed ID: 32950830
    [Abstract] [Full Text] [Related]

  • 4. Systematic review and meta-analysis of randomized controlled trials on the role of mometasone in adenoid hypertrophy in children.
    Chohan A, Lal A, Chohan K, Chakravarti A, Gomber S.
    Int J Pediatr Otorhinolaryngol; 2015 Oct 05; 79(10):1599-608. PubMed ID: 26235732
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the effects of montelukast, mometasone furoate, and combined therapyon adenoid size: a randomized, prospective, clinical trial with objective data.
    Tuhanıoğlu B, Erkan SO.
    Turk J Med Sci; 2017 Dec 19; 47(6):1736-1743. PubMed ID: 29306232
    [Abstract] [Full Text] [Related]

  • 6. Objective reduction in adenoid tissue after mometasone furoate treatment.
    Rezende RM, Silveira F, Barbosa AP, Menezes UP, Ferriani VP, Rezende PH, Anselmo-Lima WT, Valera FC.
    Int J Pediatr Otorhinolaryngol; 2012 Jun 19; 76(6):829-31. PubMed ID: 22425063
    [Abstract] [Full Text] [Related]

  • 7. Is the effect of topical intranasal steroids on obstructive adenoids transient or long-lasting? Case series and systematic review of literature.
    Bitar MA, Nassar J, Dana R.
    J Laryngol Otol; 2016 Apr 19; 130(4):357-62. PubMed ID: 26847580
    [Abstract] [Full Text] [Related]

  • 8. Exploring the characteristics of children with obstructive adenoid responding to mometasone fuorate monohydrate: preliminary results.
    Bitar MA, Mahfoud L, Nassar J, Dana R.
    Eur Arch Otorhinolaryngol; 2013 Mar 19; 270(3):931-7. PubMed ID: 23010795
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of Pidotimod use in treating allergic rhinitis in a pediatric population.
    Brindisi G, Zicari AM, Schiavi L, Gori A, Conte MP, Marazzato M, De Castro G, Leonardi L, Duse M.
    Ital J Pediatr; 2020 Jul 07; 46(1):93. PubMed ID: 32635938
    [Abstract] [Full Text] [Related]

  • 16. [The effectiveness of the combination of azelastine hydrochloride and mometasone furoate for the intranasal application in the patients presenting with seasonal allergic rhinitis].
    Karpishchenko SA, Kolesnikova OM.
    Vestn Otorinolaringol; 2017 Jul 07; 82(5):44-47. PubMed ID: 29072663
    [Abstract] [Full Text] [Related]

  • 17. The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study.
    Berlucchi M, Salsi D, Valetti L, Parrinello G, Nicolai P.
    Pediatrics; 2007 Jun 07; 119(6):e1392-7. PubMed ID: 17533178
    [Abstract] [Full Text] [Related]

  • 18. Improvement in allergic and nonallergic rhinitis: A secondary benefit of adenoidectomy in children.
    Warman M, Granot E, Halperin D.
    Ear Nose Throat J; 2015 Jun 07; 94(6):220;222;224-7. PubMed ID: 26053979
    [Abstract] [Full Text] [Related]

  • 19. Combination of mometasone furoate and oxymetazoline for the treatment of adenoid hypertrophy concomitant with allergic rhinitis: A randomized controlled trial.
    Liu W, Zhou L, Zeng Q, Luo R.
    Sci Rep; 2017 Jan 18; 7():40425. PubMed ID: 28098165
    [Abstract] [Full Text] [Related]

  • 20. A comparison between mometasone furoate nasal spray and intranasal glycyrrhetic acid in patients with allergic rhinitis: a preliminary study in clinical practice.
    Gariuc L, Sandul A, Rusu D, Passali D, Bellussi LM, Damiani V, Ciprandi G.
    Acta Biomed; 2020 Feb 17; 91(1-S):65-72. PubMed ID: 32073564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.